CLX
Clorox Co.

6,982
Loading...
Loading...
News
all
press releases
Procter & Gamble Exhibits High P/E: A Buy Opportunity or Time to Wait?
PG posts solid growth and dividend strength, but its high valuation sparks debate on whether the stock is worth buying now.
Zacks·16d ago
News Placeholder
More News
News Placeholder
Will Colgate's Innovation Drive Market Share Gains in 2025?
CL's innovation push spans premium oral, personal, home and pet care to drive market share growth in 2025 despite headwinds.
Zacks·21d ago
News Placeholder
Is the Options Market Predicting a Spike in Clorox Stock?
Investors need to pay close attention to CLX stock based on the movements in the options market lately.
Zacks·29d ago
News Placeholder
Clorox Q4 Earnings Beat Estimates, Organic Sales Increase Y/Y
CLX posts 57.7% EPS growth and 8% organic sales gain in the fourth quarter, fueled by strong ERP-driven volume increases.
Zacks·1mo ago
News Placeholder
Compared to Estimates, Clorox (CLX) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Clorox (CLX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·1mo ago
News Placeholder
Clorox (CLX) Q4 Earnings and Revenues Top Estimates
Clorox (CLX) delivered earnings and revenue surprises of +28.12% and +3.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Countdown to Clorox (CLX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top-and-bottom-line estimates for Clorox (CLX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Zacks·1mo ago
News Placeholder
Clorox Pre-Q4 Earnings Send Mixed Signals: Time to Accumulate Shares?
CLX's Q4 performance is likely to have benefited from margin strength and innovation, but macro headwinds and rising costs keep investors cautious.
Zacks·1mo ago
News Placeholder
Analysts Estimate Colgate-Palmolive (CL) to Report a Decline in Earnings: What to Look Out for
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
Clorox (CLX) Reports Next Week: Wall Street Expects Earnings Growth
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago

Latest CLX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.